Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1632 1637 1646
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18688282 | LIPOPHILIC OLIGONUCLEOTIDE CONJUGATES | Non-Final OA | Vanderbilt University |
| 18274327 | COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 18251384 | ENHANCEMENT OF PREDICTABLE AND TEMPLATE-FREE GENE EDITING BY THE ASSOCIATION OF CAS WITH DNA POLYMERASE | Non-Final OA | New York University |
| 18278196 | COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH MULTIPLE ORGAN FAILURE | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
| 18263085 | COMPOSITIONS AND METHODS FOR TREATMENT OF NIEMANN PICK TYPE A DISEASE | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18484001 | MICRORNA COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF NERVOUS SYSTEM DYSFUNCTION | Final Rejection | Rutgers, The State University of New Jersey |
| 18659711 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLON CANCER INCLUDING EXTRACELLULAR VESICLES LOADED WITH MACC1 INHIBITOR AS ACTIVE INGREDIENT | Non-Final OA | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 18295036 | SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18374236 | GENE CIRCUIT, RNA DELIVERY SYSTEM AND USE THEREOF | Non-Final OA | NANJING UNIVERSITY |
| 18373605 | NUCLEIC ACID DELIVERY SYSTEM AND APPLICATION THEREOF | Non-Final OA | NANJING UNIVERSITY |
| 18263194 | COMPOUNDS AND METHODS FOR MODULATING HUNTINGTIN | Non-Final OA | Ionis Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy